Daclatasvir plus sofosbuvir regimen sheds promising light on future hepatitis C virus genotype 3 therapies

Main Article Content

Ali Murat Kahveci
Veysel Tahan

Abstract

-

Article Details

Similar Articles

<< < 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 

You may also start an advanced similarity search for this article.